Trial Profile
Pharmacokinetics of oseltamivir in patients with infection due to influenza A H1N1 2009 admitted in intensive care unit
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza A virus infections
- Focus Pharmacokinetics
- 25 Jul 2022 This trail has been completed in Belgium (End Date: 15 Jul 2013),European Clinical Trials Database record.
- 16 Jun 2011 New trial record